Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects
approximately 8%–12% of children worldwide. Throughout an individual's lifetime, ADHD …

Objective The aim of this systematic review and meta‐analysis was to examine the evidence
for the effectiveness of exercise interventions on attention deficit hyperactivity disorder …

Background Previous studies have demonstrated the short-term efficacy of
pharmacotherapy and behavior therapy for attention-deficit/hyperactivity disorder (ADHD) …

Pelham, Wheeler, and Chronis reviewed the treatment literature on attention-
deficit/hyperactivity disorder (ADHD) and concluded behavioral parent training (BPT) and …

The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called
tomoxetine or LY139603) has been shown to alleviate symptoms in Attention …

OBJECTIVE: Several studies have demonstrated differences in omega-3 fatty acid
composition in plasma and in erythrocyte membranes in patients with attention …

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder in which
patients present inattention, hyperactivity, and impulsivity. The etiology of this condition is …

Objective.—To deal with public and professional concern regarding possible
overprescription of attention-deficit/hyperactivity disorder (ADHD) medications, particularly …

Comorbidity of attention deficit hyperactivity disorder (ADHD) and reading disorder (RD) is
frequent. Comorbid subjects show a neuropsychological profile characterized by failure of …

Objective. Concerns exist that stimulant therapy of youths with attention-deficit/hyperactivity
disorder (ADHD) may result in an increased risk for subsequent substance use disorders …